European Parliament Interest Group on Allergy and Asthma: Addressing patient unmet needs in allergy and asthma care

 Registration is closed for this event

Thursday 13 January, 13.00-14.15pm (virtual event)

Allergy and asthma are among the most prevalent chronic conditions in Europe, and the most prevalent in Europe’s children. In light of the new EU Pharmaceutical Strategy for Europe, the revision of relevant legislation (medicines for children and rare diseases, general pharmaceuticals legislation), an increased focus on health research, as well as the upcoming proposal of the European Health Data Space, patient needs are and should be at the core of the EU policies going forward.

This event aims to shed light on the patient unmet needs in allergy and asthma care, against the backdrop of persistent challenges exacerbated by the COVID-19 pandemic, and a patient-centred Pharmaceutical strategy. The discussions will look into current challenges at the EU and national level, and propose policy solutions to overcome them for the benefit of patients, boosting access to high-level quality care.

The event is co-hosted by Interest Group members Co-Chairs MEP Tilly Metz (Greens/EFA-Luxembourg) and MEP Juozas Olekas (S&D- Lithuania).  

This project is made possible thanks to unrestricted grants from EFA's Sustainable Funding Partners: GSK, Chiesi, Sanofi and Regeneron.

Agenda

Welcome
13:00-13:05Opening remarks MEP Tilly Metz (Greens/EFA-Luxembourg)
Introduction: Patient unmet needs in times of change 
13:05-13:15 Patient unmet needs in allergy and asthma: Reflections on old and new needs in light of the COVID-19 pandemic 

Carla Jones, President (EFA)

 

Freja Anckers, Youth Parliament (EFA)

Panel discussion: Championing EU policy solutions to address unmet needs in allergy and asthma care (moderated)
13:15-13:50 

 

  • Current needs and challenges in allergy and asthma care

 

  • How does the EU address low-prevalent allergies and paediatric asthma

 

  • How could medicines development best serve the under-served allergy and asthma patients

 

  • How to ensure patient access to innovation in medicines

 

The views from the EP Interest Group on Allergy & Asthma

 

Prof. Jürgen Schwarze, Secretary-General (The European Academy of Allergy and Clinical Immunology)

 

DG SANTE, Unit B5 (TBC)

 

 

Tina Taube, Director Market Access & Orphan Drug Policy Lead (EFPIA - European Federation of Pharmaceutical Industries and Associations)

Dr Stanimir Hasardzhiev, Secretary-General, Patient Access Partnership (PACT) 

 

Moderator: Isabel Proaño Director of Policy and Communications, (EFA) 

13:50-14:10Q&A with audience (moderated) 
Closing remarks
14:10-14:15Concluding remarks and way forwardMEP Juozas Olekas (S&D- Lithuania)
When
13th January, 2022 1:00 PM through  2:15 PM
Location
Virtual event on Zoom
Brussels,
Belgium
Contact
Phone: +3222272712

Dear Visitor,

for regularly updated information on Covid-19 for allergy and respiratory patients, please consult our Covid-19 resource and information hub.
Stay safe!
The EFA Team